Filing Details
- Accession Number:
- 0000899243-18-006980
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-09 18:00:50
- Reporting Period:
- 2018-03-07
- Accepted Time:
- 2018-03-09 18:00:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374690 | Zafgen Inc. | ZFGN | Pharmaceutical Preparations (2834) | 203857670 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611048 | E. Thomas Hughes | C/O Zafgen, Inc. 175 Portland Street, 4Th Floor Boston MA 02114 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-03-07 | 5,000 | $10.00 | 157,247 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018.
Billionaire Hedge Funds
